Cargando…
Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats
BACKGROUND: Iron chelators are used to treat iron overload cardiomyopathy patients. However, a direct comparison of the benefits of three common iron chelators (deferoxamine (DFO), deferiprone (DFP) and deferasirox (DFX)) or an antioxidant (N-acetyl cysteine (NAC)) with a combined DFP and NAC treatm...
Autores principales: | Wongjaikam, Suwakon, Kumfu, Sirinart, Khamseekaew, Juthamas, Sripetchwandee, Jirapas, Srichairatanakool, Somdet, Fucharoen, Suthat, Chattipakorn, Siriporn C., Chattipakorn, Nipon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948821/ https://www.ncbi.nlm.nih.gov/pubmed/27428732 http://dx.doi.org/10.1371/journal.pone.0159414 |
Ejemplares similares
-
Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine
por: Wongjaikam, Suwakon, et al.
Publicado: (2017) -
Combined Therapy of Iron Chelator and Antioxidant Completely Restores Brain Dysfunction Induced by Iron Toxicity
por: Sripetchwandee, Jirapas, et al.
Publicado: (2014) -
An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
por: Theerajangkhaphichai, Wasan, et al.
Publicado: (2021) -
Author Correction: An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
por: Theerajangkhaphichai, Wasan, et al.
Publicado: (2023) -
Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia
por: Sripetchwandee, Jirapas, et al.
Publicado: (2018)